UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Trims Stock Position in Transcat, Inc. (NASDAQ:TRNS)

UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC trimmed its stake in Transcat, Inc. (NASDAQ:TRNS) by 11.1% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 13,722 shares of the scientific and technical instruments company’s stock after selling 1,719 shares during the period. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC owned 0.15% of Transcat worth $1,657,000 as of its most recent SEC filing.

A number of other large investors have also recently modified their holdings of TRNS. Conestoga Capital Advisors LLC lifted its stake in shares of Transcat by 17.9% in the 3rd quarter. Conestoga Capital Advisors LLC now owns 907,191 shares of the scientific and technical instruments company’s stock valued at $109,561,000 after purchasing an additional 137,830 shares during the period. Calamos Advisors LLC lifted its position in Transcat by 76.0% during the second quarter. Calamos Advisors LLC now owns 15,441 shares of the scientific and technical instruments company’s stock valued at $1,848,000 after buying an additional 6,667 shares during the period. Millrace Asset Group Inc. bought a new position in shares of Transcat in the 3rd quarter worth about $655,000. Champlain Investment Partners LLC increased its stake in shares of Transcat by 22.1% in the 3rd quarter. Champlain Investment Partners LLC now owns 409,500 shares of the scientific and technical instruments company’s stock worth $49,455,000 after acquiring an additional 74,169 shares in the last quarter. Finally, First Horizon Advisors Inc. lifted its position in Transcat by 26.4% during the 2nd quarter. First Horizon Advisors Inc. now owns 599 shares of the scientific and technical instruments company’s stock valued at $72,000 after acquiring an additional 125 shares during the period. Institutional investors own 98.34% of the company’s stock.

Transcat Price Performance

Shares of NASDAQ:TRNS opened at $109.21 on Tuesday. Transcat, Inc. has a 1 year low of $94.29 and a 1 year high of $147.12. The company has a market cap of $1.00 billion, a P/E ratio of 55.16 and a beta of 0.70. The stock’s fifty day moving average price is $111.17 and its 200-day moving average price is $119.18.

Transcat (NASDAQ:TRNS) last posted its earnings results on Monday, October 28th. The scientific and technical instruments company reported $0.35 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.47 by ($0.12). Transcat had a net margin of 6.63% and a return on equity of 7.36%. The company had revenue of $67.83 million for the quarter, compared to the consensus estimate of $70.30 million. During the same quarter in the prior year, the company posted $0.41 EPS. Transcat’s revenue was up 8.0% on a year-over-year basis. On average, sell-side analysts anticipate that Transcat, Inc. will post 1.76 earnings per share for the current year.

Wall Street Analysts Forecast Growth

A number of equities analysts have weighed in on the stock. Craig Hallum raised their target price on shares of Transcat from $113.00 to $125.00 and gave the company a “buy” rating in a research note on Thursday, December 12th. Oppenheimer reiterated an “outperform” rating and set a $130.00 price objective (down previously from $155.00) on shares of Transcat in a research note on Wednesday, October 30th. HC Wainwright restated a “buy” rating and set a $156.00 price target on shares of Transcat in a report on Tuesday, October 29th. Northland Securities lowered their price target on Transcat from $130.00 to $110.00 and set a “market perform” rating for the company in a research report on Wednesday, October 30th. Finally, StockNews.com downgraded shares of Transcat from a “hold” rating to a “sell” rating in a research report on Tuesday, October 29th. One research analyst has rated the stock with a sell rating, two have issued a hold rating and three have assigned a buy rating to the company. Based on data from MarketBeat, Transcat currently has an average rating of “Hold” and an average target price of $130.25.

Transcat Company Profile

Transcat, Inc provides calibration and laboratory instrument services in the United States, Canada, and internationally. It operates through two segments: Service and Distribution. The Service segment offers calibration, repair, inspection, analytical qualification, preventative maintenance, consulting, and other related services.